Skip to search formSkip to main contentSkip to account menu

A 5610

Known as: A-5610 
National Institutes of Health

Related topics

Related topics

9 relations

Broader (9)

Anti-Allergic AgentsAnti-Inflammatory Agents, Non-SteroidalAzelastine hydrochlorideBronchodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Protective property of azelastine against histamine challenge of rhinal mucosa in domestic pigs.
In anaesthetized domestic pigs a filter paper sampling technique was applied to estimate basal and histamine induced nasal… 
1991
1991
Effects of antiallergic drugs on superoxide anion generation from activated human alveolar macrophages measured by chemiluminescence method.
Human alveolar macrophages were recovered by bronchoalveolar lavage and superoxide anion (O2-) generation from the macrophages… 
1991
1991
Effects of azelastine on superoxide anion generation from gamma interferon treated human monoblast cell line U937 measured by chemiluminescence method.
U937 cells are established human monoblast cell line originally isolated from a patient with diffuse histiocytic lymphoma. In the… 
1990
1990
Inhibitory effects of azelastine on protein kinase C and diphosphoinositide kinase in rat mast cells.
Rat mast cells purified on a Percoll gradient were challenged with compound 48/80 and protein kinase C activity in the cell… 
1979
1979
Anti-allergic properties of a new histamine antagonist, 4-(p-chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine).
Anti-allergic properties of 4-(p-chlorobenzyl)-2 [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)